Personal Profile
Professor Andrew Baildam is a leading oncoplastic breast surgeon based in Greater Manchester and London, who specialises in all areas of breast health including breast surgery, breast reconstruction and breast cancer, particularly in women who have a family history of the disease.
Professor Baildam trained in surgical oncology and then additionally plastic and reconstructive breast surgery, and was appointed as a consultant surgeon and an honorary senior lecturer in surgical oncology at The Christie Hospital, Manchester. He was then appointed to St Bartholomew’s Hospital as the Professor of Breast and Oncoplastic Surgery, Queen Mary University of London. After 36 years in the NHS he now works in the independent sector.
As he holds a keen interest in patients with genetic breast cancer and oncoplastic breast surgery, Professor Baildam has over 200 peer-reviewed publications, abstracts and chapters, and has innovated a number of approaches to breast cancer surgery. Professor Baildam is past President of The Associate of Cancer Surgery and the Chair of Royal College of Surgeons of England Cancer Surgery Committee. He pioneered the cross-specialty breast surgery oncoplastic training fellowships in the UK.
Professor Baildam trained in surgical oncology and then additionally plastic and reconstructive breast surgery, and was appointed as a consultant surgeon and an honorary senior lecturer in surgical oncology at The Christie Hospital, Manchester. He was then appointed to St Bartholomew’s Hospital as the Professor of Breast and Oncoplastic Surgery, Queen Mary University of London. After 36 years in the NHS he now works in the independent sector.
As he holds a keen interest in patients with genetic breast cancer and oncoplastic breast surgery, Professor Baildam has over 200 peer-reviewed publications, abstracts and chapters, and has innovated a number of approaches to breast cancer surgery. Professor Baildam is past President of The Associate of Cancer Surgery and the Chair of Royal College of Surgeons of England Cancer Surgery Committee. He pioneered the cross-specialty breast surgery oncoplastic training fellowships in the UK.
